Related Experiment Video
Updated: May 13, 2025
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Notable surgical trials in gynecologic oncology: a 10-year overview
José C Vilches1, María Clara Santía2, Elise Mann Yates2
1Department of Obstetrics and Gynecology, Hospital Quironsalud Malaga, Malaga, Spain.
Abstract:
In the last decade, we have witnessed important advances in novel therapeutics in the management of gynecologic cancers. These studies have built on the findings from preexisting data and have provided incremental contributions leading to changes that have not only impacted the accuracy of cancer detection and its metastatic components but also led to improvements in oncologic outcomes and quality of life. Key landmark trials have changed the standard of care in cervix, uterine, and ovarian cancer. A number of these have been controversial and have generated significant debate among gynecologic oncologists. The main objective of this review was to provide an overview on each of these trials as a reference for immediate and consolidated access to the study aims, methodology, results, and conclusion.
Insights
Recent advances in gynecologic oncology have improved cancer detection and patient outcomes. Landmark trials in cervical, uterine, and ovarian cancers have significantly changed treatment standards, sparking debate among experts.
Area of Science:
- Gynecologic Oncology
- Cancer Therapeutics
- Clinical Trials
Background:
- Significant progress in novel therapeutics for gynecologic cancers over the past decade.
- Advances impact cancer detection, metastasis assessment, and patient outcomes.
- Landmark clinical trials have reshaped standards of care for cervix, uterine, and ovarian cancers.
Purpose of the Study:
- To review key landmark trials in gynecologic cancer management.
- Provide consolidated access to trial aims, methodology, results, and conclusions.
- Serve as a reference for oncologists navigating treatment changes and controversies.
Main Methods:
- Review of pivotal clinical trials in gynecologic oncology.
- Analysis of trial data focusing on aims, methodology, results, and conclusions.
- Synthesis of findings to highlight changes in the standard of care.
Main Results:
- Identification of key trials that have altered management strategies for cervical, uterine, and ovarian cancers.
- Documentation of improvements in oncologic outcomes and quality of life.
- Acknowledgment of controversial findings and ongoing debates within the field.
Conclusions:
- Novel therapeutics and landmark trials have substantially advanced gynecologic cancer care.
- These studies offer critical insights into treatment efficacy and patient benefit.
- Understanding these trials is essential for current and future oncologic practice.
